Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IMPDH2 | P12268 | 4/20 | 0.33 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.31 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | LATS1 | O95835 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30637695 | 1.00 | IMPDH2 (0.33) | IMPDH2IMPDH1CYP11B1CYP11B2AAK1 | |
| SCHEMBL29675203 | 0.78 | RAB9A (0.42) | LMNAPKM | |
| SCHEMBL23324992 | 0.78 | RAB9A (0.42) | LMNAPKM | |
| SCHEMBL27083154 | 0.76 | NOTUM (0.43) | LMNA | |
| SCHEMBL27083198 | 0.76 | RAB9A (0.34) | — | |
| SCHEMBL30637693 | 0.76 | RAB9A (0.34) | — | |
| SCHEMBL29635359 | 0.75 | CYP1A1 (0.32) | CYP11B1CYP11B2 | |
| SCHEMBL22042745 | 0.75 | CYP1A1 (0.32) | CYP11B1CYP11B2 | |
| SCHEMBL23324042 | 0.75 | ADORA2A (0.35) | — | |
| SCHEMBL23302331 | 0.74 | RORC (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12583847-B2 | Fluorinated pyrimidine compound and method for producing same | UNIMATEC CO., LTD. (JP) | 2026-03-24 | — | — | US | disclosed |
| US-20240190853-A1 | FLUORINATED PYRIMIDINE COMPOUND AND METHOD FOR PRODUCING SAME | UNIMATEC CO., LTD. (JP) | 2024-06-13 | — | — | US | disclosed |
| EP-4317154-A1 | FLUORINATED PYRIMIDINE COMPOUND AND METHOD FOR PRODUCING SAME | Unimatec Co., Ltd. (JP) | 2024-02-07 | — | — | EP | disclosed |
| CN-117043158-A | Fluorine-containing pyrimidine compound and process for producing the same | 优迈特株式会社 | 2023-11-10 | — | — | CN | disclosed |
| WO-2022202537-A1 | FLUORINATED PYRIMIDINE COMPOUND AND METHOD FOR PRODUCING SAME | ユニマテック株式会社 | 2022-09-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240190853-A1 | FLUORINATED PYRIMIDINE COMPOUND AND METHOD FOR PRODUCING SAME | POF1B, CCNA1, AOC2 | IMPDH2 760/4885IMPDH1 403/4885CYP11B1 310/4885 |
| US-12583847-B2 | Fluorinated pyrimidine compound and method for producing same | NAF1, CCNA1, HAO1 | IMPDH2 1642/4885IMPDH1 618/4885CYP11B1 111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.